L

Ligand Pharmaceuticals
D

LGND

120.680
USD
-1.35
(-1.11%)
مغلق
حجم التداول
3,190
الربح لكل سهم
6
العائد الربحي
-
P/E
48
حجم السوق
2,280,293,614
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.350
    (-1.73%)
    19.940 USD
    A
    AGIO
    1.430
    (4.23%)
    35.210 USD
    ALNY
    ALNY
    -0.480
    (-0.19%)
    250.450 USD
    B
    BLUE
    -2.93000
    (-41.68%)
    4.10000 USD
    I
    INCY
    0.790
    (1.11%)
    72.150 USD
    J
    JAZZ
    -0.640
    (-0.47%)
    136.050 USD
    N
    NBIX
    4.630
    (3.99%)
    120.710 USD
    VRTX
    VRTX
    4.10
    (0.85%)
    484.53 USD
    المزيد
الأخبار
المقالات

العنوان: Ligand Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license andmilestone payments, and sale of its trademarked Captisol material.